Inside the COURAGE Trial: Design and Methodology The randomized, double-blind COURAGE trial evaluated the efficacy and safety of trevogrumab, with or without garetosmab, in combination with semaglutide in 999 patients
But recent headlines have raised questions about their impact on the eyes, from short-lived blurred vision to very rare eye conditions
Does Ipamorelin raise cortisol
The treatments popularity is growing, but patients should carefully manage expectations and consult certified professionals before deciding
Rare but Serious Risks These can include pancreatitis or gallbladder issues, so its important to monitor any unusual symptoms
Currently, semaglutide is approved for people with a BMI of 30 or more, the BMI used to define obesity